TFAP2A (Transcription Factor AP-2 alpha) is a transcription factor that plays a crucial role in various cellular processes, including cell growth, differentiation, and survival. In the context of cancer, TFAP2A has been implicated in both tumor suppression and oncogenesis, depending on the type of cancer and the cellular context.
TFAP2A has been shown to act as a tumor suppressor in certain types of cancer, such as breast cancer, where it regulates the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair.
On the other hand, TFAP2A has also been implicated in the development and progression of other types of cancer, such as melanoma, where it promotes cell proliferation, survival, and metastasis.
Transcription Factor AP-2 alpha (TFAP2A) is an important regulatory protein that plays multifaceted roles in normal development and cancer biology. Its impact on tumor progression and prognosis is complex, reflecting its ability to function as both a tumor suppressor and, in some contexts, as an oncogenic factor. Variations in its expression and activity across different cancers underscore its potential utility as a prognostic biomarker and a target for therapy.
(Will delete Record if Target field = "Delete") Home